SurePulse
SurePulse is developing highly accurate heart rate measuring technology designed specifically for babies who need stabilisation or resuscitation at birth.
Medical device – newborn monitoring
Faculty of Engineering
Profile
SurePulse is dedicated to transforming neonatal care with wireless vital sign monitoring technology designed specifically for newborns. Founded in 2014 as a joint venture between the University of Nottingham and Tioga Ltd, SurePulse aims to place babies and their families at the centre of neonatal monitoring, supporting better outcomes from birth to home.
SurePulse’s entry level product, the VS wireless heart rate monitoring cap, is CE-marked and FDA-cleared. The company has now developed its next-generation wireless multi-parameter patch integrating ECG, oxygen saturation and temperature, having successfully completed clinical trials at Nottingham University Hospitals.
These patented wireless technologies enables quick application, fast signal acquisition, and reduces stress in the delivery room – supporting optimal cord clamping and strengthening early parent-infant bonding through skin-to-skin contact and Kangaroo Care.
The formation of two spin-out companies has enabled our technology to reach and benefit the lives of so many mothers and babies around the world.
It has been a challenging, but worthwhile journey that I would be eager to repeat and I encourage all of my colleagues to follow this highly rewarding path.
Professor Barrie Hayes-Gill, Faculty of Engineering
Founder of SurePulse Medical Ltd
Gallery
